What is the significance of a 38-year-old male's iron level of 52 micrograms per deciliter (mcg/dL), Total Iron-Binding Capacity (TIBC) of 371 mcg/dL, and iron saturation of 14 percent, indicating hypoferritinemia and low iron saturation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Based on your lab results, you have low iron levels and low iron saturation, which suggests iron deficiency, and I strongly recommend starting an oral iron supplement to replenish your iron stores. According to the British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults 1, iron deficiency should be confirmed by iron studies prior to investigation, and serum ferritin is the single most useful marker of IDA. Although your serum ferritin levels are not provided, your low iron and iron saturation levels are indicative of iron deficiency.

To manage your iron deficiency, I recommend starting an oral iron supplement such as ferrous sulfate 325 mg once or twice daily, taken on an empty stomach with vitamin C (like orange juice) to enhance absorption, as suggested by the guidelines 1. It is essential to take this supplement for at least 3 months to replenish your iron stores, then repeat your blood tests to monitor improvement.

Some key points to consider when taking iron supplements include:

  • Avoid taking iron with calcium, dairy products, coffee, tea, or antacids as these can reduce absorption
  • Common side effects include constipation and stomach upset, which can be managed by starting with a lower dose and gradually increasing, or by switching to a gentler formulation like ferrous gluconate
  • Iron deficiency can cause fatigue, weakness, and reduced exercise tolerance, so supplementation should help improve these symptoms
  • Your TIBC (Total Iron Binding Capacity) is normal, which indicates your body has adequate capacity to bind and transport iron, but your current iron levels are insufficient to meet your body's needs. A good response to iron therapy, as defined by the guidelines 1, is a haemoglobin rise ≥10 g/L within a 2-week timeframe, which would confirm the diagnosis of absolute iron deficiency.

From the Research

Iron Deficiency Anemia

  • The provided lab results show low iron levels (52 mcg/dL) and low iron saturation (14%) in the patient's blood, indicating iron deficiency anemia 2, 3.
  • The patient's Total Iron-Binding Capacity (TIBC) is within the normal range (371 mcg/dL), which suggests that the patient's body is able to bind iron, but the iron levels are still low 4.

Treatment Options

  • Oral iron-replacement therapy is the mainstay of treatment for iron-deficiency anemia, but it is often poorly tolerated or ineffective 2.
  • Ferrous sulfate is a commonly used iron supplement, but it can cause gastrointestinal side effects 3, 5.
  • Lactoferrin supplementation has been shown to have better effects on serum iron and hemoglobin levels compared to ferrous sulfate, with fewer side effects 3.
  • Sucrosomial iron supplementation has been shown to be effective in patients with celiac disease who are intolerant to oral ferrous sulfate 4.
  • Intravenous iron sucrose has been shown to be effective in correcting peripartum anemia, although oral iron can also be effective 6.

Response to Treatment

  • A ≥1.0-g/dL increase in hemoglobin at day 14 of oral iron therapy can predict a satisfactory overall hemoglobin response to oral iron 2.
  • Hemoglobin responses <1.0 g/dL at day 14 of oral iron identify patients who should be transitioned to intravenous iron supplementation 2.
  • Iron-replacement therapy can improve quality of life and reduce fatigue in patients with iron-deficiency anemia 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intravenous iron sucrose versus oral iron ferrous sulfate for antenatal and postpartum iron deficiency anemia: a randomized trial.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.